TickerFacts.

Bio Essence Corp (BIOE): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.43M
Year ended 2025-12-31
$2.03M
Trailing 12 months to 2026-06-30
+63.2%
3-year compound annual growth
2020-12-31: $227.3K2021-12-31: $298.3K2022-12-31: $328.3K2023-12-31: $277.4K2024-12-31: $217.1K2025-12-31: $1.43M$1.43M
2020-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.43M+558.0%2026-03-27, From 2025-01-01
2024-12-31$217.1K-21.8%2026-03-27, From 2024-01-01
2023-12-31$277.4K-15.5%2024-04-15, From 2023-01-01
2022-12-31$328.3Kn/c2024-04-15, From 2022-01-01
2021-12-31$298.3K+31.3%2023-03-30, From 2021-01-01
2020-12-31$227.3Kn/a2022-03-31, From 2020-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Bio Essence Corp (BIOE)2025-12-31$1.43M+558.0%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$940.0Kn/a
Cannapharmarx, Inc. (CPMD)2025-12-31-$2.08Mn/m
IGC Pharma, Inc. (IGC)2025-03-31$619.0K-15.6%
Longeveron Inc. (LGVN)2025-12-31$803.0K-57.4%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$248.7K-32.3%
Bespoke Extracts, Inc. (BSPK)2024-12-31$452.9K+32.0%
Dare Bioscience, Inc. (DARE)2025-12-31$734.4Kn/a
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$223.8K+0.4%

Compare BIOE, NRXP, CPMD, IGC side by side · Screen every company in Pharmaceutical Preparations ↗